Karina Tazhibayeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karina Tazhibayeva has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Aigul Myrzabekova
Astana Medical University, Astana 010000, Kazakhstan
5 shared publications - Antonio Sarria-Santamera
Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan
4 shared publications - Milan Terzic
Department of Surgery, School of Medicine, Nazarbayev University, Zhanybek-Kerey Khans Street 5/1, Astana 010000, Kazakhstan
4 shared publications - Zaituna Khamidullina
Department of Obstetrics and Gynecology #1, NJSC “Astana Medical University”, Astana 010000, Kazakhstan
4 shared publications - Gauri Bapayeva
Clinical Academic Department of Women’s Health, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan
3 shared publications - Kymbat Mukhtarova
Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan
3 shared publications
Latest Publications
- Open Access
- 1 June 2025
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 14 (6) , 1818-1826
Silymarin as a promising antioxidant for sperm cryopreservation: a narrative review
Background and Objective: Sperm cryopreservation is a key technology in preserving male fertility, particularly for patients undergoing chemotherapy, radiotherapy, or those with compromised semen quality. However, the cryopreservation and thawing processes frequently lead to oxidative stress, resulting in significant deterioration of sperm motility, viability, morphology, and DNA integrity. This review explores the potential role of plant-derived antioxidants in mitigating cryodamage, focusing on silymarin—a polyphenolic flavonoid extracted from Silybum marianum. The objective is to evaluate the effect of silymarin on post-thaw sperm parameters in comparison to traditional antioxidants such as vitamin C and vitamin E. Methods: This narrative review was conducted by systematically searching PubMed, Scopus, Web of Science, and ScienceDirect for publications between 2015 and 2025. Relevant studies examining the influence of silymarin and other antioxidants on sperm cryopreservation outcomes were identified and analyzed. Emphasis was placed on experimental models that assessed motility, viability, morphology, DNA fragmentation, and reactive oxygen species (ROS) levels. Key Content and Findings: Findings suggest that all three antioxidants demonstrate potential in enhancing post-thaw sperm quality. However, silymarin consistently exhibited superior effects on sperm motility, membrane integrity, and antioxidant defense, particularly when used at optimized concentrations. Despite these promising results, clinical protocols for silymarin remain undeveloped. Conclusions: Silymarin shows promise as a multifunctional antioxidant for improving post-cryopreservation sperm quality. Its incorporation into assisted reproductive technology (ART) protocols may enhance reproductive outcomes. Further clinical research is needed to validate its efficacy and determine optimal dosing for human applications.
- 1 June 2025
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 14 (6) , 1818-1826
Open AccessSilymarin as a promising antioxidant for sperm cryopreservation: a narrative review
Background and Objective: Sperm cryopreservation is a key technology in preserving male fertility, particularly for patients undergoing chemotherapy, radiotherapy, or those with compromised semen quality. However, the cryopreservation and thawing processes frequently lead to oxidative stress, resulting in significant deterioration of sperm motility, viability, morphology, and DNA integrity. This review explores the potential role of plant-derived antioxidants in mitigating cryodamage, focusing on silymarin—a polyphenolic flavonoid extracted from Silybum marianum. The objective is to evaluate the effect of silymarin on post-thaw sperm parameters in comparison to traditional antioxidants such as vitamin C and vitamin E. Methods: This narrative review was conducted by systematically searching PubMed, Scopus, Web of Science, and ScienceDirect for publications between 2015 and 2025. Relevant studies examining the influence of silymarin and other antioxidants on sperm cryopreservation outcomes were identified and analyzed. Emphasis was placed on experimental models that assessed motility, viability, morphology, DNA fragmentation, and reactive oxygen species (ROS) levels. Key Content and Findings: Findings suggest that all three antioxidants demonstrate potential in enhancing post-thaw sperm quality. However, silymarin consistently exhibited superior effects on sperm motility, membrane integrity, and antioxidant defense, particularly when used at optimized concentrations. Despite these promising results, clinical protocols for silymarin remain undeveloped. Conclusions: Silymarin shows promise as a multifunctional antioxidant for improving post-cryopreservation sperm quality. Its incorporation into assisted reproductive technology (ART) protocols may enhance reproductive outcomes. Further clinical research is needed to validate its efficacy and determine optimal dosing for human applications.
- Open Access
- 17 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (24) , 7705
Predicting Intensive Care Unit Admission in COVID-19-Infected Pregnant Women Using Machine Learning
Background: The rapid onset of COVID-19 placed immense strain on many already overstretched healthcare systems. The unique physiological changes in pregnancy, amplified by the complex effects of COVID-19 in pregnant women, rendered prioritization of infected expectant mothers more challenging. This work aims to use state-of-the-art machine learning techniques to predict whether a COVID-19-infected pregnant woman will be admitted to ICU (Intensive Care Unit). Methods: A retrospective study using data from COVID-19-infected women admitted to one hospital in Astana and one in Shymkent, Kazakhstan, from May to July 2021. The developed machine learning platform implements and compares the performance of eight binary classifiers, including Gaussian naïve Bayes, K-nearest neighbors, logistic regression with L2 regularization, random forest, AdaBoost, gradient boosting, eXtreme gradient boosting, and linear discriminant analysis. Results: Data from 1292 pregnant women with COVID-19 were analyzed. Of them, 10.4% were admitted to ICU. Logistic regression with L2 regularization achieved the highest F1-score during the model selection phase while achieving an AUC of 0.84 on the test set during the evaluation stage. Furthermore, the feature importance analysis conducted by calculating Shapley Additive Explanation values points to leucocyte counts, C-reactive protein, pregnancy week, and eGFR and hemoglobin as the most important features for predicting ICU admission. Conclusions: The predictive model obtained here may be an efficient support tool for prioritizing care of COVID-19-infected pregnant women in clinical practice.
- 17 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (24) , 7705
Open AccessPredicting Intensive Care Unit Admission in COVID-19-Infected Pregnant Women Using Machine Learning
Background: The rapid onset of COVID-19 placed immense strain on many already overstretched healthcare systems. The unique physiological changes in pregnancy, amplified by the complex effects of COVID-19 in pregnant women, rendered prioritization of infected expectant mothers more challenging. This work aims to use state-of-the-art machine learning techniques to predict whether a COVID-19-infected pregnant woman will be admitted to ICU (Intensive Care Unit). Methods: A retrospective study using data from COVID-19-infected women admitted to one hospital in Astana and one in Shymkent, Kazakhstan, from May to July 2021. The developed machine learning platform implements and compares the performance of eight binary classifiers, including Gaussian naïve Bayes, K-nearest neighbors, logistic regression with L2 regularization, random forest, AdaBoost, gradient boosting, eXtreme gradient boosting, and linear discriminant analysis. Results: Data from 1292 pregnant women with COVID-19 were analyzed. Of them, 10.4% were admitted to ICU. Logistic regression with L2 regularization achieved the highest F1-score during the model selection phase while achieving an AUC of 0.84 on the test set during the evaluation stage. Furthermore, the feature importance analysis conducted by calculating Shapley Additive Explanation values points to leucocyte counts, C-reactive protein, pregnancy week, and eGFR and hemoglobin as the most important features for predicting ICU admission. Conclusions: The predictive model obtained here may be an efficient support tool for prioritizing care of COVID-19-infected pregnant women in clinical practice.
- Open Access
- 19 November 2024
- Published by MDPI AG in Preprints.org
Predicting Intensive Care Unit Admission in COVID-19 Infected Pregnant Women Using Machine Learning
Background: The rapid onset of COVID-19 placed immense strain on many already overstretched healthcare systems. The unique physiological changes of pregnancy, amplified by the complex effects of COVID-19 in pregnant women, rendered prioritization of infected expectant mothers more challenging. This work aims to use state-of-the-art machine learning techniques to predict whether a COVID-19-infected pregnant woman will be admitted to ICU (Intensive Care Unit). Methods: A retrospective study using data from COVID-19 infected women admitted to 2 hospital 1 in Astana and 1 in Shymkent, Kazakhstan, from May to July 2021. The developed machine learning platform implements and compares the performance of eight binary classifiers including Gaussian naïve Bayes, K-nearest neighbors, logistic regression with L2 regularization, random forest, AdaBoost, gradient boosting, eXtreme gradient boosting, and linear discriminant analysis. Results: Data from 1168 pregnant women with COVID-19 was analyzed. From them, 9.4% were admitted to ICU. Logistic regression with L2 regularization achieved the highest F1-score during the model selection phase while achieving an AUC of 0.84 on the test set during the evaluation stage. Furthermore, the feature importance analysis conducted by calculating Shapley Additive Explanation values points to leucocyte counts, C-reactive protein, pregnancy week, and eGFR and hemoglobin as the most important features for predicting ICU admission. Conclusion: The predictive model here obtained may be an efficient support tool for prioritizing care of COVID-19 infected pregnant women in clinical practice.
- 19 November 2024
- Published by MDPI AG in Preprints.org
Open AccessPredicting Intensive Care Unit Admission in COVID-19 Infected Pregnant Women Using Machine Learning
Background: The rapid onset of COVID-19 placed immense strain on many already overstretched healthcare systems. The unique physiological changes of pregnancy, amplified by the complex effects of COVID-19 in pregnant women, rendered prioritization of infected expectant mothers more challenging. This work aims to use state-of-the-art machine learning techniques to predict whether a COVID-19-infected pregnant woman will be admitted to ICU (Intensive Care Unit). Methods: A retrospective study using data from COVID-19 infected women admitted to 2 hospital 1 in Astana and 1 in Shymkent, Kazakhstan, from May to July 2021. The developed machine learning platform implements and compares the performance of eight binary classifiers including Gaussian naïve Bayes, K-nearest neighbors, logistic regression with L2 regularization, random forest, AdaBoost, gradient boosting, eXtreme gradient boosting, and linear discriminant analysis. Results: Data from 1168 pregnant women with COVID-19 was analyzed. From them, 9.4% were admitted to ICU. Logistic regression with L2 regularization achieved the highest F1-score during the model selection phase while achieving an AUC of 0.84 on the test set during the evaluation stage. Furthermore, the feature importance analysis conducted by calculating Shapley Additive Explanation values points to leucocyte counts, C-reactive protein, pregnancy week, and eGFR and hemoglobin as the most important features for predicting ICU admission. Conclusion: The predictive model here obtained may be an efficient support tool for prioritizing care of COVID-19 infected pregnant women in clinical practice.
- Open Access
- 30 October 2024
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 17 (12) , 102572
Characterization of COVID-19 infected pregnant women with ICU admission and the risk of preterm: A cluster analysis
- 30 October 2024
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 17 (12) , 102572
Open AccessCharacterization of COVID-19 infected pregnant women with ICU admission and the risk of preterm: A cluster analysis
- Open Access
Association of ACE2 Gene Variants with Adverse Perinatal Outcomes in COVID-19 Infected Pregnant Women in Kazakhstan
SARS-CoV-2 utilizes the angiotensin-converting enzyme 2 (ACE2) receptors located on membranes to enter host cells. Nevertheless, the ACE2 gene primarily encodes for a zinc metalloproteinase, which is a part of the renin–angiotensin system (RAS). ACE2 downregulation results in the deregulation of RAS in favor of pro-fibrosis, pro-apoptosis, oxidative stress, pro-inflammation, aldosterone production and release, and blood vessel contraction axis. ACE2 is highly expressed in the placenta. There are both axes of the RAS system in the placenta. This study aims to assess the perinatal outcomes with ACE2 receptor polymorphisms in pregnant women infected with SARS-CoV-2 during pregnancy. The case-control study was conducted to determine the association of ACE2 single-nucleotide polymorphisms in 171 COVID-19-positive pregnant subjects and 112 control subjects. The recessive mutations of rs2158082 and rs4830974 were associated with an increased risk of low birthweight and preterm birth, whereas the dominant mutation of rs2285666 (CT + TT) was associated with decreased odds of low birthweight. COVID-19 was not a significant factor contributing to the adverse perinatal outcomes in our sampling. These findings may help to clarify the controversy regarding the increased risk of adverse perinatal outcomes observed during COVID-19 as well as provide new perspectives for research on the genetic factors associated with a higher risk of adverse perinatal outcomes.
Open AccessAssociation of ACE2 Gene Variants with Adverse Perinatal Outcomes in COVID-19 Infected Pregnant Women in Kazakhstan
SARS-CoV-2 utilizes the angiotensin-converting enzyme 2 (ACE2) receptors located on membranes to enter host cells. Nevertheless, the ACE2 gene primarily encodes for a zinc metalloproteinase, which is a part of the renin–angiotensin system (RAS). ACE2 downregulation results in the deregulation of RAS in favor of pro-fibrosis, pro-apoptosis, oxidative stress, pro-inflammation, aldosterone production and release, and blood vessel contraction axis. ACE2 is highly expressed in the placenta. There are both axes of the RAS system in the placenta. This study aims to assess the perinatal outcomes with ACE2 receptor polymorphisms in pregnant women infected with SARS-CoV-2 during pregnancy. The case-control study was conducted to determine the association of ACE2 single-nucleotide polymorphisms in 171 COVID-19-positive pregnant subjects and 112 control subjects. The recessive mutations of rs2158082 and rs4830974 were associated with an increased risk of low birthweight and preterm birth, whereas the dominant mutation of rs2285666 (CT + TT) was associated with decreased odds of low birthweight. COVID-19 was not a significant factor contributing to the adverse perinatal outcomes in our sampling. These findings may help to clarify the controversy regarding the increased risk of adverse perinatal outcomes observed during COVID-19 as well as provide new perspectives for research on the genetic factors associated with a higher risk of adverse perinatal outcomes.
- Open Access
- 23 August 2022
- Published by NpJSC "Astana Medical University" in Astana Medical Journal
- No. S1,p. 266-270
СЛУЧАЙ МАТЕРИНСКОГО ЗЕРКАЛЬНОГО СИНДРОМА
Зеркальный синдром, также называемый синдромом Баллантина, является редким состоянием во время беременности, определяемым наличием клинической триады: водянкой плода, плацентомегалией и отеком матери. Синдром водянки плода может быть вызван любой этиологией, в том числе резус-изоиммунизацией, врожденной инфекцией, переливанием крови от близнеца к близнецу, структурными аномалиями и злокачественными новообразованиями плода. Патогенез, хотя и недостаточно установленный, имитирует трофобластическое повреждение и дисфункцию эндотелия сосудов у матери, что также наблюдается при преэклампсии, и, следовательно, эти два состояния могут иметь сходную клиническую картину. Они могут даже сосуществовать, когда у пациентки с синдромом материнского зеркала развиваются признаки преэклампсии. Для предотвращения внутриутробной смертности и материнской заболеваемости необходимы своевременная, точная диагностика и оперативное вмешательство.
- 23 August 2022
- Published by NpJSC "Astana Medical University" in Astana Medical Journal
- No. S1,p. 266-270
Open AccessСЛУЧАЙ МАТЕРИНСКОГО ЗЕРКАЛЬНОГО СИНДРОМА
Зеркальный синдром, также называемый синдромом Баллантина, является редким состоянием во время беременности, определяемым наличием клинической триады: водянкой плода, плацентомегалией и отеком матери. Синдром водянки плода может быть вызван любой этиологией, в том числе резус-изоиммунизацией, врожденной инфекцией, переливанием крови от близнеца к близнецу, структурными аномалиями и злокачественными новообразованиями плода. Патогенез, хотя и недостаточно установленный, имитирует трофобластическое повреждение и дисфункцию эндотелия сосудов у матери, что также наблюдается при преэклампсии, и, следовательно, эти два состояния могут иметь сходную клиническую картину. Они могут даже сосуществовать, когда у пациентки с синдромом материнского зеркала развиваются признаки преэклампсии. Для предотвращения внутриутробной смертности и материнской заболеваемости необходимы своевременная, точная диагностика и оперативное вмешательство.